Revaccination With Locally-Produced Vi Typhoid Polysaccharide Vaccine Among Chinese School-Aged Children-Reference-Cited by-同舟云学术

Revaccination With Locally-Produced Vi Typhoid Polysaccharide Vaccine Among Chinese School-Aged Children

Published:2007-11 Issue:11 Volume:26 Page:1001-1005
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Zhou Wei-Zhong,Koo Hye-Won,Wang Xuan-Yi,Zhang Jun,Park Jin-Kyung,Zhu Fengcai,Deen Jacqueline,Acosta Camilo J.,Chen Yan,Wang Hua,Galindo Claudia M.,Ochiai Leon,Park Taesung,von Seidlein Lorenz,Xu Zhi-Yi,Clemens John D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference22 articles.

1. The global burden of typhoid fever.;Crump;Bull WHO,2004

2. Achievement of control and prevention on typhoid fever in China.;He;Zhong Hua Liu Xing Bing Xue Za Zhi,2000

3. Safety and immune efficacy of Salmonella typhi Vi capsular polysaccharide vaccine.;Xie;Zhong Guo Sheng Wu Zhi Pin Xue Za Zhi,1998

4. Comparison on the reactogenicity and immunogenicity of China-made and Merieux produced Salmonella typhi Vi polysaccharide vaccines.;Zhou;Zhong Guo Gong Gong Wei Shen,1999

5. Study on immunogenicity of Vi polysaccharide typhoid vaccine.;Zhou;Zhong Guo Gong Gong Wei Sheng,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses;Frontiers in Immunology;2023-03-23

2. Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses;2023-01-03

3. Typhoid Fever Vaccines;Plotkin's Vaccines;2023

4. Vaccines and Senior Travellers;Frontiers in Aging;2021-07-09

5. Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead;Clinical Infectious Diseases;2020-07-29